Summary & Overview

Shoulder, Elbow or Forearm Procedures, Except Major Joint Procedures with MCC: Inpatient Reimbursement Overview

DRG 510 encompasses inpatient procedures on the shoulder, elbow, or forearm, excluding major joint replacements, when a Major Complication or Comorbidity is present; it covers complex repair and reconstructive interventions that drive higher resource use. This grouping matters for inpatient reimbursement because the Diagnosis-Related Group assignment with a Major Complication or Comorbidity influences Medicare payment levels and resource-intensity classification.

Shoulder proceduresElbow proceduresForearm proceduresDRG Shoulder, Elbow or Forearm Procedures, Except Major Joint Procedures with MCCDRG 510Diagnosis-Related GroupInpatient ReimbursementMedicareOrthopedicsUpper extremity surgery

DRG 510 Overview

DRG 510 covers inpatient hospital cases involving procedures on the shoulder, elbow, or forearm that are not classified as major joint procedures and that include a Major Complication or Comorbidity. Typical cases include complex repair, reconstruction, or fixation of distal upper extremity structures where the presence of a Major Complication or Comorbidity increases resource use. This Diagnosis-Related Group matters for Medicare payment because it groups clinically similar resource-intensive admissions for reimbursement weighting. Hospitals use the DRG assignment to determine the base payment for these inpatient stays under Medicare rules.

Clinical Trials

Acute operative technique and perioperative care trials focusing on minimally invasive versus open surgical approaches for proximal humerus, distal clavicle, or complex elbow fractures in older adults; these studies enroll patients admitted for shoulder, elbow, or forearm procedures to compare short-term outcomes such as blood loss, operative time, in-hospital complication rates, and length of stay. They are relevant because procedural choice and perioperative protocols directly affect inpatient resource use, complication-related costs, and immediate discharge disposition for DRG 510 patients.
Comparative effectiveness studies of fixation hardware and biologic adjuncts (for example, different plate designs, intramedullary nails, suture-anchor constructs, or bone graft substitutes) in non-major-joint reconstructive procedures of the shoulder, elbow, and forearm; these trials typically enroll a broad adult population with traumatic or degenerative indications undergoing reconstructive procedures and evaluate functional outcomes, reoperation rates, and cost-effectiveness over 6–24 months. Payers and providers benefit from this research because device selection and reoperation risk drive medium-term costs and readmission rates that impact bundled payments and DRG-related utilization.
Post-discharge rehabilitation and outcomes research assessing timing, intensity, and setting (inpatient vs outpatient vs home-based) of physical and occupational therapy after shoulder, elbow, or forearm procedures; these observational cohort studies and pragmatic trials follow patients discharged from the index hospitalization to measure functional recovery, return-to-work, pain control, and post-acute healthcare utilization. This area is important to stakeholders managing DRG 510 because differences in post-discharge pathways influence readmissions, outpatient service use, long-term disability expenditures, and overall value of the inpatient episode.

Related Codes

540-OSTEOMYELITIS-WITH-CC

Osteomyelitis with Complication or Comorbidity: Inpatient Reimbursement Overview

557-TENDONITIS-MYOSITIS-AND-BURSITIS-WITH-MCC

Tendonitis, Myositis and Bursitis with MCC: Inpatient Reimbursement Overview

521-HIP-REPLACEMENT-WITH-PRINCIPAL-DIAGNOSIS-OF-HIP-FRACTURE-WITH-MCC

Hip Replacement with Principal Diagnosis of Hip Fracture with MCC: Inpatient Reimbursement Overview

430-COMBINED-ANTERIOR-AND-POSTERIOR-CERVICAL-SPINAL-FUSION-WITHOUT-MCC

Combined Anterior and Posterior Cervical Spinal Fusion without MCC: Inpatient Reimbursement Overview

501-SOFT-TISSUE-PROCEDURES-WITH-CC

Soft Tissue Procedures with CC: Inpatient Reimbursement Overview

522-HIP-REPLACEMENT-WITH-PRINCIPAL-DIAGNOSIS-OF-HIP-FRACTURE-WITHOUT-MCC

Hip Replacement with Principal Diagnosis of Hip Fracture without MCC: Inpatient Reimbursement Overview

447-MULTIPLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-MCC-OR-CUSTOM-MADE-ANATOMICALLY-DESIGNED-INTERBODY-FUSION-DEVICE

Multiple Level Spinal Fusion Except Cervical with MCC: Inpatient Reimbursement Overview

492-LOWER-EXTREMITY-AND-HUMERUS-PROCEDURES-EXCEPT-HIP-FOOT-AND-FEMUR-WITH-MCC

Lower Extremity and Humerus Procedures with MCC: Inpatient Reimbursement Overview

498-LOCAL-EXCISION-AND-REMOVAL-OF-INTERNAL-FIXATION-DEVICES-OF-HIP-AND-FEMUR-WITH-CC-MCC

Local Excision and Removal of Internal Fixation Devices of Hip and Femur with CC/MCC: Inpatient Reimbursement Overview

516-OTHER-MUSCULOSKELETAL-SYSTEM-AND-CONNECTIVE-TISSUE-O-R-PROCEDURES-WITH-CC

Other Musculoskeletal System and Connective Tissue O.R. Procedures with CC: Inpatient Reimbursement Overview

Showing 1–10 of 104

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.